Clinical Trial

Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer

Name: Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer — clinical trial record (NCT07166263)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This study will evaluate the safety and efficacy of NK510 in the treatment of relapsed and refractory advanced gastric cancer and colorectal cancer.NK510 will be administered by intravenous infusion for systemic therapy and intraperitoneal perfusion therapy. The safety and efficacy of this treatment will be evaluated.

Trial Details

NCT Number	NCT07166263
Lead Sponsor	Base Therapeutics (Shanghai) Co., Ltd.
Conditions	Gastric Cancer (GC), Colorectal Cancer
Enrollment	15 participants
Start Date	2025-11
Primary Completion	2027-06 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2025-09-10